NgospelMedia.Net
NgospelMedia.net is The No. 1 International Urban Gospel Media Website, The Largest Repository of Your Favorite Gospel Entertainment Website, Worldwide, Nigeria. We Published Latest Nigerian and Foreign Gospel Music Downloads, Videos; Lyrics, Artiste Biography, Daily Devotionals. NgospelMedia is mainly a Christian Website, as the Domain Name Speaks; Gospel; Which is also tagged as a Gospel On-line Ministry for Souls Winning... 

- related posts -

Canada approves COVID-19 vaccine

12

- Advertisement -









Canada has become the second country after the UK to approve the Covid-19 vaccine.

The country’s health regulator, Health Canada, made this known in a statement released via its website on Wednesday.

According to the statement, the Pfizer/BioNTech vaccine was approved after a two-month independent review on safety and efficacy.

“Canadians should feel confident that the review of the vaccine was thoroughly done and that we equally have strong monitoring systems in place.

“Health Canada and the Public Health Agency of Canada will closely monitor the safety of the vaccine once it is on the market and will not hesitate to take further action if any safety concerns are been identified.

“The immunization is, however, only approved for Canadians above the age of 16 for now could be recommended later to include children once more data is released from its the ongoing clinical trials,” the statement said.

Also, the Canadian Prime Minister, Justin Trudeau had on Monday said that Canada would get up to 249,000 doses of the vaccine before the end of December, while 4 million doses of the vaccine are expected by March 2021.

Recall that UK had announced that it began administering the COVID-19 vaccine making it the first country to approve Pfizer’s coronavirus vaccine.

 

- Advertisement -

Subscribe to our newsletter
Sign up here to get the latest news, updates and special offers delivered directly to your inbox.
You can unsubscribe at any time

- Advertisement -

- related posts -

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More